Stephanie Trunk’s Insights

317 total results. Page 17 of 27.

Health Care Counsel Blog
PhRMA Faces Setback – For Now – In Challenge to California’s New Drug Price Transparency Law
Health Care Counsel Blog
Seize the Opportunity: HHS Seeks Stakeholder Input on AKS Safe Harbors and CMP Exceptions to Ease Regulatory Burdens on Care Coordination
Health Care Counsel Blog
It’s About More Than Hospitals: CY 2019 Proposed Hospital Outpatient Prospective Payment System Rule Contains Proposals of Interest to the Pharmaceutical Industry
Health Care Counsel Blog
Fourth Circuit Denies Maryland’s Request for En Banc Rehearing: Drug Price-Gouging Law Remains Unconstitutional
Events
World Congress’ Copay Summit
July 23, 2018
Health Care Counsel Blog
CY 2019 Medicare Physician Fee Schedule and Part B Proposed Rule Signals Payment Reduction for New Part B Drugs
Health Care Counsel Blog
Proposed Regulations Implementing California’s Drug Price Transparency Law Available for Public Comment
Health Care Counsel Blog
PhRMA and BIO Drop their Lawsuit Challenging Nevada’s Drug Price Transparency Law
Health Care Counsel Blog
Building an In-House Team from the Ground-Up: One Leader’s Experience
Events
GPO Membership Eligibility and Class of Trade Maintenance Forum
June 19, 2018
Events
CBI’s 14th Annual Medical Device Compliance Congress
Health Care Counsel Blog
California and Nevada Agencies Move Ahead with Drug Price Transparency Rule Making